Medicinal product name Fintepla
Pharmaceutical form Oral solution
Strength 2.2 mg/ml 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code N03AX26 Antiepileptics

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(264 mg/120 ml)
HDPE bottle    EU/1/20/1491/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/20/1491/002
Date of authorisation Dec 18, 2020
Marketing authorisation holder, country UCB Pharma S.A., Belgium